Pages that link to "Item:Q1715304"
From MaRDI portal
The following pages link to Evolution of resistance to anti-cancer therapy during general dosing schedules (Q1715304):
Displaying 24 items.
- A mathematical model for the dynamics of cancer hepatocytes under therapeutic actions (Q285210) (← links)
- Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases (Q326548) (← links)
- Spatio-genetic and phenotypic modelling elucidates resistance and re-sensitisation to treatment in heterogeneous melanoma (Q1739290) (← links)
- An elementary mathematical modeling of drug resistance in cancer (Q1980067) (← links)
- A modified fluctuation test for elucidating drug resistance in microbial and cancer cells (Q2068578) (← links)
- Different costs of therapeutic resistance in cancer: short- and long-term impact of population heterogeneity (Q2085123) (← links)
- A multiscale model to design therapeutic strategies that overcome drug resistance to tyrosine kinase inhibitors in multiple myeloma (Q2173889) (← links)
- Stochastic modeling of drug resistance in cancer (Q2195074) (← links)
- Competition delays multi-drug resistance evolution during combination therapy (Q2225995) (← links)
- Understanding the role of phenotypic switching in cancer drug resistance (Q2297830) (← links)
- Modeling continuous levels of resistance to multidrug therapy in cancer (Q2307049) (← links)
- Practically scheduling hormone therapy for prostate cancer using a mathematical model (Q2317045) (← links)
- A quasi birth-and-death model for tumor recurrence (Q2324900) (← links)
- Phase-specific cancer-immune model considering acquired resistance to therapeutic agents (Q2661016) (← links)
- Inferring density-dependent population dynamics mechanisms through rate disambiguation for logistic birth-death processes (Q2689528) (← links)
- Optimal control problems for differential equations applied to tumor growth: state of the art (Q2690605) (← links)
- Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies (Q2839156) (← links)
- An Evolutionary Perspective on Cancer, with Applications to Anticancer Drug Resistance Modelling and Perspectives in Therapeutic Control (Q3307888) (← links)
- Drug concentration heterogeneity facilitates the evolution of drug resistance (Q4230628) (← links)
- Scheduling Chemotherapy: Catch 22 between Cell Kill and Resistance Evolution (Q4489320) (← links)
- Optimizing Chemoradiotherapy to Target Metastatic Disease and Tumor Growth (Q5131724) (← links)
- Deterministic and Stochastic Dynamics of Chronic Myelogenous Leukaemia Stem Cells Subject to Hill-Function-Like Signaling (Q5253369) (← links)
- A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence (Q6080346) (← links)
- On minimising tumoural growth under treatment resistance (Q6136591) (← links)